Consistent with our results, a subset of proteomic studies has found decreased TRMT1 protein levels in SARS-CoV-2-infected human cells as well as in post-mortem tissue samples from deceased COVID-19 patients (Bojkova et al., 2020; Nie et al., 2021). This evidence concerns the gene TRMT1 and COVID-19.